Associations of Low-Intensity Resistance Training with Body Composition and Lipid Profile in Obese Patients with Type 2 Diabetes

被引:15
作者
Hamasaki, Hidetaka [1 ,2 ]
Kawashima, Yu [1 ]
Tamada, Yoshiki [3 ]
Furuta, Masashi [4 ]
Katsuyama, Hisayuki [1 ]
Sako, Akahito [1 ]
Yanai, Hidekatsu [1 ]
机构
[1] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Internal Med, Chiba, Japan
[2] Jichi Med Univ, Grad Sch, Community Healthcare Studies, Gen Internal Med, Shimotsuke, Tochigi, Japan
[3] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Rehabil, Chiba, Japan
[4] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Nutr, Chiba, Japan
关键词
LIPOPROTEIN(A) LEVELS; SARCOPENIC OBESITY; INSULIN-RESISTANCE; PHYSICAL-EXERCISE; OLDER-ADULTS; MUSCLE; METABOLISM; STRENGTH; MEN;
D O I
10.1371/journal.pone.0132959
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Resistance training to increase muscle mass and functional capacity is an integral part of diet and exercise programs for the management of obesity and type 2 diabetes. Low-intensity resistance training with slow movement and tonic force generation (LST) may be a practical and safe regimen for elderly obese individuals but the health benefits are uncertain. This study investigated the effects of LST on body composition and metabolic parameters in obese patients with type 2 diabetes. Twenty-six obese patients with type 2 diabetes engaged in LST training during hospitalization and were advised to maintain this regimen for 12 weeks after discharge. We compared lipid profile, arterial stiffness, and body composition before and after LST training. After 12 weeks of LST training, the ratio of lower extremity muscle mass to body weight increased significantly (0.176 +/- 0.028 to 0.184 +/- 0.023, mean +/- SD), while body fat mass and body fat percentage decreased significantly (36.2 +/- 10.9 kg to 34.3 +/- 9.4 kg and 41.2 +/- 8.6% to 40.1 +/- 7.7%, respectively). Moreover, high-density lipoprotein cholesterol was significantly increased (42.2 +/- 14 mg/dl to 46.3 +/- 12.4 mg/dl) and both free fatty acids and lipoprotein(a) were decreased (665.2 +/- 212.1 mu Eq/l to 525.4 +/- 231.3 mu Eq/l and 15.4 +/- 18 mg/dl to 13.8 +/- 18 mg/dl, respectively). No significant change was observed in arterial stiffness. Although this study was a non-controlled investigation and some confounding factors including dietary intake, medication and compliance with training might affect the study result, a brief (12-week) LST training program may be a safe and effective strategy for the management of obesity and type 2 diabetes.
引用
收藏
页数:10
相关论文
共 38 条
[11]   LIPIDS AND ENDURANCE PHYSICAL-ACTIVITY [J].
HELLSTEN, G ;
BOMAN, K ;
HALLMANS, G ;
DAHLEN, G .
ATHEROSCLEROSIS, 1989, 75 (01) :93-94
[12]   Resistance training for obese, type 2 diabetic adults: a review of the evidence [J].
Hills, A. P. ;
Shultz, S. P. ;
Soares, M. J. ;
Byrne, N. M. ;
Hunter, G. R. ;
King, N. A. ;
Misra, A. .
OBESITY REVIEWS, 2010, 11 (10) :740-749
[13]   Acute effects of treadmill running on lipoprotein(a) levels in males and females [J].
Hubinger, L ;
Mackinnon, LT ;
Barber, L ;
Mccosker, J ;
Howard, A ;
Lepre, F .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1997, 29 (04) :436-442
[14]   The effect of endurance training on lipoprotein(a) [Lp(a)] levels in middle-aged males [J].
Hubinger, L ;
Mackinnon, LT .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1996, 28 (06) :757-764
[15]   Skeletal muscle lipid metabolism with obesity [J].
Hulver, MW ;
Berggren, JR ;
Cortright, RN ;
Dudek, RW ;
Thompson, RP ;
Pories, WJ ;
MacDonald, KG ;
Cline, GW ;
Shulman, GI ;
Dohm, GL ;
Houmard, JA .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (04) :E741-E747
[16]   Strength Training as a Countermeasure to Aging Muscle and Chronic Disease [J].
Hurley, Ben F. ;
Hanson, Erik D. ;
Sheaff, Andrew K. .
SPORTS MEDICINE, 2011, 41 (04) :289-306
[17]   Fate of fatty acids at rest and during exercise: regulatory mechanisms [J].
Jensen, MD .
ACTA PHYSIOLOGICA SCANDINAVICA, 2003, 178 (04) :385-390
[18]   Metabolic and body composition factors in subgroups of obesity: What do we know? [J].
Karelis, AD ;
St-Pierre, DH ;
Conus, F ;
Rabasa-Lhoret, R ;
Poehlman, ET .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2569-2575
[19]  
KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307
[20]  
Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130